



Travel-related acquisition of diarrhoeagenic bacteria,
enteral viruses and parasites in a prospective cohort
of 98 Dutch travellers
Citation for published version (APA):
van Hattem, J. M., Arcilla, M. S., Grobusch, M. P., Bart, A., Bootsma, M. C., van Genderen, P. J., van
Gool, T., Goorhuis, A., van Hellemond, J. J., Molenkamp, R., Molhoek, N., lashof, A. M. O., Stobberingh,
E. E., de Wever, B., Verbrugh, H. A., Melles, D. C., Penders, J., Schultsz, C., & de Jong, M. D. (2017).
Travel-related acquisition of diarrhoeagenic bacteria, enteral viruses and parasites in a prospective cohort
of 98 Dutch travellers. Travel Medicine and Infectious Disease, 19, 33-36.
https://doi.org/10.1016/j.tmaid.2017.08.003





Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.




Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 03 Nov. 2021
lable at ScienceDirect
Travel Medicine and Infectious Disease 19 (2017) 33e36Contents lists avaiTravel Medicine and Infectious Disease
journal homepage: www.elsevierheal th.com/journals / tmidTravel-related acquisition of diarrhoeagenic bacteria, enteral viruses
and parasites in a prospective cohort of 98 Dutch travellers
Jarne M. van Hattem a, *, Maris S. Arcilla b, Martin P. Grobusch c, Aldert Bart a, d,
Martin C. Bootsma e, f, Perry J. van Genderen g, Tom van Gool d, Abraham Goorhuis c,
Jaap J. van Hellemond b, Richard Molenkamp a, Nicky Molhoek g, Astrid M. Oude Lashof h,
Ellen E. Stobberingh h, Bob de Wever a, Henri A. Verbrugh b, Damian C. Melles b,
John Penders h, Constance Schultsz a, Menno D. de Jong a
a Department of Medical Microbiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
b Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Centre, Rotterdam, The Netherlands
c Center of Tropical Medicine and Travel Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
d Department of Parasitology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
e Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands
f Department of Mathematics, Faculty of Science, Utrecht University, Utrecht, The Netherlands
g Institute for Tropical Diseases, Havenziekenhuis, Rotterdam, The Netherlands
h School for Public Health and Primary Care (Caphri), Department of Medical Microbiology, Maastricht University Medical Centre, Maastricht, The
Netherlandsa r t i c l e i n f o
Article history:
Received 8 June 2017
Received in revised form
20 July 2017
Accepted 21 August 2017








E-mail address: j.m.vanhattem@amc.uva.nl (J.M. v
http://dx.doi.org/10.1016/j.tmaid.2017.08.003
1477-8939/© 2017 Elsevier Ltd. All rights reserved.a b s t r a c t
Background: Limited prospective data are available on the acquisition of viral, bacterial and parasitic
diarrhoeagenic agents by healthy individuals during travel.
Methods: To determine the frequency of travel associated acquisition of 19 pathogens in 98 interconti-
nental travellers, qPCR was used to detect 8 viral pathogens, 6 bacterial enteric pathogens and 5 parasite
species in faecal samples collected immediately before and after travel.
Results: We found high pre-travel carriage rates of Blastocystis spp. and Dientamoeba fragilis of 32% and
19% respectively. Pre-travel prevalences of all other tested pathogens were below 3%. Blastocystis spp.
(10%), Plesiomonas shigelloides (7%), D. fragilis (6%) and Shigella spp. (5%) were the most frequently ac-
quired pathogens and acquisition of enteral viruses and hepatitis E virus in this relatively small group of
travellers was rare or non-existent.
Conclusions: Our findings suggest that the role of viruses as the cause of persisting traveller's diarrhoea is
limited and bacterial pathogens are more likely as a cause of traveller's diarrhoea. The substantial pro-
portion of travellers carrying Blastocystis spp. and D. fragilis before travel warrants cautious interpreta-
tion of positive samples in returning travellers with gastrointestinal complaints.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Although diarrhoea ranges in the top of the most frequently
occurring travel associated conditions [1], limited data are available
on the acquisition of viral, bacterial and parasitic diarrhoeagenic
agents by previously healthy individuals during travel. In addition
to the epidemiological relevance, such data may help to understandan Hattem).the clinical relevance of detected pathogens in the era of extremely
sensitive diagnostic testing with real-time PCR (qPCR). This study
was initiated to determine the frequency of travel associated
acquisition of 19 (entero)pathogens by qPCR.
2. Materials & methods
2.1. Study population
The COMBAT-study is a multicenter longitudinal cohort study
primarily focussing on the acquisition of ESBL- and
J.M. van Hattem et al. / Travel Medicine and Infectious Disease 19 (2017) 33e3634carbapenemase-producing Enterobacteriaceae [2,3]. A total of 2001
Dutch adults travelling intercontinentally for 1e12 weeks were
included from November 2012 until November 2013. All subjects
received a faeces collection swab (Fecal Swab; Copan, Brescia, Italy)
with transport medium and a questionnaire before and after travel.
The questionnaires comprised information about previous travel,
health, travel destination and behaviour during travel. Stool sam-
ples were stored at 80 C for future analysis. For this study, 100
travellers were randomly selected from the complete study popu-
lation of 2001 travellers.
2.2. Extraction and PCR
Automated nucleic acid extraction was performed using the
MagNA Pure 96 instrument (Roche Applied Science, Roche Di-
agnostics B.V., the Netherlands) with the inclusion of internal
controls for generic RNA and DNA. Reverse-transcriptase PCR was
applied immediately after extraction to form cDNA. qPCR was
performed using the LightCycler480 (Roche Applied Science, Roche
Diagnostics B.V., the Netherlands) to detect 8 viral pathogens, 6
bacterial enteric pathogens and 5 parasite species in faecal samples
collected immediately before and after travel (see Table 1 for tar-
geted micro-organisms and Supplementary Table for primer and
probe sequences). A positive (Phocine Herpesvirus, PhoHV) and
negative extraction control (STAR-buffer) were included in every
qPCR run.
2.3. Descriptive and statistical analysis
Acquisition was defined as a negative pre-travel and a positive
post-travel test result for the examined micro-organism, irre-
spective of signs and symptoms of illness. Acquisition rates were
calculated for travellers with a negative pre-travel test: the popu-
lation at risk. Traveller's diarrhoea (TD) was defined as three or
more unformed stools within a 24-h period during travel.
3. Results
For one of the 100 randomly selected travellers a sample was
missing, and for another one, DNA extraction failed. Therefore, 98
travellers were analysed. Distributions of the population charac-
teristics were similar to the distributions in the full study popula-
tion (Table 2). The median age was 48 years (range 19e75) and 53%
was female. Median travel duration was 20 (7e72) days. Most
frequently visited sub-regions were South-Eastern Asia (n ¼ 30),
South America (n ¼ 13) and Eastern Africa (n ¼ 10). Thirty-five
percent of travellers (34/97) reported TD.
Pre-travel carriage rates for Blastocystis spp. and Dientamoeba
fragilis were 31/98 (32%) and 19/98 (19%), respectively of which
seven participants carried both species (Table 3). Pre-travel prev-
alences of the other tested species were much lower and ranged
from 0 to 3%. A total of six travellers carried one or more pathogenicTable 1
Micro-organisms studied by qPCR in the cohort of travellers.
Viruses Bacteria Parasites
Adenovirus (40, 41, 52) Campylobacter spp. Blastocystis spp.
Astrovirus Clostridium difficile Cryptosporidium spp.
Enterovirus Plesiomonas shigelloides Dientamoeba fragilis
Hepatitis E virus Salmonella spp. Entamoeba histolytica
Norovirus Shigella spp. Giardia lamblia
Parechovirus Yersinia enterocolitica
Rotavirus (A, C)
Sapovirusbacteria before travel. None of these six travellers had diarrhoeal
complaints before travel.
Blastocystis spp. were acquired most frequently, followed by
Plesiomonas shigelloides, Dientamoeba fragilis and Shigella spp.
(Table 3). Pathogenic bacteria were acquired by 19/98 (19%) of
travellers, of whom 7 acquired P. shigelloides.
Entamoeba histolytica, Cryptosporidium spp., Rotavirus (A, C),
Adenovirus (40, 41, 52), Astrovirus and Sapovirus were neither
detected in any of the pre-travel samples nor in the post-travel
samples. Hepatitis E virus (HEV) was detected in 2 pre-travel
samples only. Norovirus and Parechovirus were both acquired by
two travellers and Enterovirus by one traveller, respectively. Of
note, the traveller who acquired an Enterovirus travelled to China
only and did not visit a polio-endemic area.
4/5 travellers that acquired Shigella spp. and 3/4 that acquired
Campylobacter spp. reported TD (OR 8.0; p¼ 0.054 by Fisher's exact
test and OR 6.0; p ¼ 0.12 respectively). Of the 7 travellers that ac-
quired P. shigelloides only one reported TD (OR 0.3; p ¼ 0.42)
(Table 3).
4. Discussion
This study shows that Dientamoeba fragilis and Blastocystis spp.
were highly prevalent before travel. Blastocystis spp., Plesiomonas
shigelloides, Dientamoeba fragilis and Shigella spp. were the most
frequently acquired pathogens and acquisition of enteral viruses
and HEV in this relatively small group of travellers was rare or non-
existent.
To our knowledge, travel associated acquisition of a wide spec-
trum of nineteen viral, bacterial and parasite species has not been
reported before. The PCR's used for this study are validated and
used for routine diagnostics and are considered very sensitive.
However, as with all molecular tests, the detection of DNA does not
necessarily mean that detected pathogens are viable. Also, the
possibility exists that pathogens acquired during travel were
already cleared by time the traveller returned and did the post
travel sampling, and some brief intermittent acquisitions may
therefore have been missed in this analysis. However, post-travel
samples were provided within a mean of 3 days (range 0e19
days; median 2 days) and the mean duration between sample
collection and processing in the laboratory was 2 days (range 1e23
days) so we do not regard this possibility as a significant source of
bias. A major limitation of this study is the sample size that is
probably too small to detect rarely acquired enteropathogens.
Therefore, no firm conclusions on the acquisition of HEV and other
rare pathogens can be drawn from this study. Also, an association
between the acquisition of studied microorganisms and TD was not
found, but because a limited number of travellers were tested, the
statistical power to study this association was low. Unfortunately
we were not able to study Cyclospora cayetanensis, which is
considered an important parasitic cause of traveller's diarrhoea in
some regions [4].
L€a€averi and co-workers performed a prospective study on bac-
terial TD pathogens in 382 Finnish travellers [5] and found acqui-
sition of Salmonella spp. and Shigella/EIEC to be slightly lower than
in the present study; namely 2.4% and 0.8% respectively; and
Campylobacter was acquired by slightly more (6.8%) travellers.
However, they did not test for Clostridium, Yersinia, Plesiomonas,
parasites and viruses.
A non-prospective case-control study in 114 returning travellers
with diarrhoea and 56 travellers without diarrhoea [6] found 19/
170 (11.2%) to be positive by microscopy for Blastocystis spp. after
travel and only one positive forDientamoeba fragilis. Probably, these
lower post-travel prevalences are the result of lower diagnostic
sensitivity of microscopy compared to PCR. Interestingly, they
Table 2
Baseline characteristics of current study group and the full study population.
current study, n/N
(n ¼ 98a)
full study population, n/N
(n ¼ 2001a)
Female 51/97 (53%) 1079/1996 (54%)
Median age, years (range) 48 (19e76) 51 (18e82)
Median travel duration, days (range) 20 (7e72) 20 (3e105)
Chronic illness 17/97 (18%) 450/1977 (23%)
Antibiotic use last 3 months 11/98 (11%) 197/1988 (10%)
Diarrhoea pre-travel 10/97 (10%) 242/1993 (12%)
Travel reason: vacation 84/97 (87%) 1655/1964 (84%)
Travellers' diarrhoea 34/97 (35%) 734/1962 (37%)
Travel destination:
South-Eastern Asia 30/97 (31%) 578/1965 (29%)
South America 13/97 (13%) 192/1965 (10%)
Eastern Africa 10/97 (10%) 206/1965 (10%)
Northern Africa 7/97 (7%) 83/1965 (4%)
Multiple sub-regions in Asia 6/97 (6%) 76/1965 (4%)
Western Africa 4/97 (4%) 114/1965 (4%)
Other sub-regions 27/97 (28%) 716/1965 (36%)
a Numbers do not always add up to 98 and 2001 because of missing data.
Table 3






TDb % No TDb % Total
Bacteria
Campylobacter spp. 0 0% 3/34 9% 1/63 2% 4/98 (4%)
Clostridium difficile 0 0% 1/34 3% 0/63 0% 1/98 (1%)
Plesiomonas shigelloides 1 1% 1/34 3% 6/62 10% 7/97 (7%)
Salmonella spp. 0 0% 2/34 6% 1/63 2% 3/98 (3%)
Shigella spp. 2 2% 4/34 12% 1/61 2% 5/96 (5%)
Yersinia enterocolitica 3 3% 2/33 6% 0/61 0% 2/95 (2%)
Parasites
Blastocystis spp. 31 32% 3/25 12% 4/41 10% 7/67 (10%)
Cryptosporidium spp. 0 0% 0
Dientamoeba fragilis 19 19% 1/24 4% 4/54 7% 5/79 (6%)
Entamoeba histolytica 0 0% 0
Giardia lamblia 0 0% 0/34 0% 1/63 2% 1/98 (1%)
Viruses
Adenovirus (40, 41, 52) 0 0% 0
Astrovirus 0 0% 0
Enterovirus 0 0% 1/34 3% 0/63 0% 1/98 (1%)
Hepatitis E virus 2 2% 0
Norovirus 1 1% 2/34 6% 0/62 0% 2/97 (2%)
Parechovirus 0 0% 0/34 0% 2/63 3% 2/98 (2%)
Rotavirus (A, C) 0 0% 0
Sapovirus 0 0% 0
TD: traveller's diarrhoea.
Numbers add up to 97 instead of 98 because of one missing post travel
questionnaire.
a Acquisition rates were calculated for travellers with a negative pre-travel test:
the ‘population at risk’.
b Denominator is the number travellers with and without TD.
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spp., whereas in the present study only one acquisition of Giardia
lamblia and no Cryptosporidium spp. was found. In their study, PCR
for Norovirus was positive in 10.5% of the cases and 3.6% of the
controls, whereas we found only 2.1% acquisition in the total
studied population. The observed differences might be explained
by a selection towards a more symptomatic population in the study
by Paschke [6], because all of their participants presented as pa-
tients to the Department of Infectious Diseases of which two-third
with diarrhoea [6].
Travel associated acquisition of HEV is a potential threat to blood
safety [7], but no acquisitions were found in the present study.
Accordingly, in a Dutch study, no seroconversions to anti-HEV werefound in 1206 travellers to (sub)tropical countries [8]. An Australian
study estimated the risk of acquiring HEV to be 0.01 to 18 per
10,000 travellers [7] indicating that our limited sample size likely is
too small to reliably determine travel-associated acquisition of HEV.
Furthermore, the incubation period of symptomatic HEV infections
is approximately 40 days (range 2e10 weeks) [9], hence infections
may be missed by analysis of samples that were collected shortly
after return.
The low acquisition rates of enteric viruses during travel could
indicate that the role of viruses as the cause of persisting TD is
limited or that viral RNA or DNA is rapidly cleared before returning.
For Norovirus however, virus is shed for a median of 28 days after
inoculation in previously healthy persons [10] and for Rotavirus,
median duration of shedding is approximately 3 weeks [11]. Since
bacterial pathogens were acquired more often, they are likely to be
more important as a cause of traveller's diarrhoea. For Blastocystis
and Dientamoeba, pathogenicity of these parasites is under debate.
To that end, a positive test in a symptomatic returning traveller
must be interpreted with caution, keeping in mind that a sub-
stantial proportion probably would already have been carrier
before travel.
Since Blastocystis spp were acquired relatively often, it would be
interesting to study if acquisition could be assigned to specific
travel destinations.
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